IndraLab
Statements
USP9X activates cell population proliferation. 62 / 67
|
62
reach
"Piao et al.,[136] reported USP22 to be activated in OSCC and increased expression of USP22 exhibited a marked propensity toward highly malignant clinical behavior, lymph node metastasis, and poor survival after surgery suggesting its role as a prognostic indicator predicting the treatment outcome of OSCC.Nanayakkara et al.[137] reported that the deubiquitylating enzyme, USP9X, possibly promotes head and neck cancer cell proliferation through the mTOR pathway."
reach
"Taking into account the numerous functions of deubiquitinating modification observed in human tumors, DUB enzymes are important in the development of HNSCC; for example, USP9X [30] and USP22 [31] promote HNSC cell proliferation, and CYLD1 [32] and BPLF1 [33] accelerate HNSCC development by inhibiting the immune cell escape mechanism or by promoting the spread of viral infection."
reach
"These differences in sensitivity appear to be directly related to the knockout efficiency of various techniques and further support the conclusion that USP9X is important for regulating RIT1-driven drug resistance.As expected, USP9X knockout impaired the proliferation of RIT1-mutant cells in erlotinib (Figure 2A)."
reach
"USP9X overexpression in MCF-7 and MDA-MB-231 breast cancer increased cell proliferation and survival, significantly reduced the number of cells in the G1-phase cells and increased the number of cells in the S-phase cells, which were reversed by CRISPR/caspase-9 USP9X gene knockout."